oncology
CONTENT HIGHLIGHT
Read our Proof-of-concept study that demonstrates how HUB Organoids can streamline the entire preclinical drug development process, resulting in significant savings in time, cost, and resources.
organoid screening
Dr. Robert Vries, CEO
Toxicology
Dr. Sylvia F. Boj, Chief Scientific Officer
organoid screening
Dr. Sylvia F. Boj, Chief Scientific Officer
Blog
Mammalian organ systems face a constant barrage of internal and external stressors, leading to cellular attrition and functional decline. Maintaining...
Blog
Inflammatory Bowel Disease (IBD) is a complex condition that affects millions worldwide. Understanding its nuances is crucial for patients, caregivers,...
Blog
In this post of our "Ask the Experts" series, we provide comprehensive answers to frequently asked questions regarding the practical...
oncology
Cell Rep | April 2023
toxicology
Eur J Pharm Sci | July 2023
infectious disease
eLife | July 2021
cystic fibrosis
J Cyst Fibros | May 2021
inflammatory bowel disease
J Vis Exp | July 2021
oncology
Cell | May 2015
